Roche Venture Fund is a private equity general partner firm headquartered in Basel, Switzerland and has other offices in United States.
Vivet Therapeutics, a French emerging biotechnology company, has raised €37.5m in a Series A from Novartis Venture Fund and others.
Biopharmaceutical company SutroVax has raised $60m in Series B from Frazier Healthcare Partners, Pivotal bioVenture Partners and others.
Tioma Therapeutics, which develops anti-CD47 antibodies that treat solid and hematologic cancers, has secured $86min Series A financing.
Read more news concerning Roche Venture Fund
A sampling of Roche Venture Fund portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?